Article
Transformation of NSCLC to SCLC harboring EML4-ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review.
Lung cancer (Amsterdam, Netherlands) - 1 Dec 2023
Lingling Xu, Maoxi Chen, Wei Ye, Jieting Zhao, Yuanyuan Yao, Ning Xu
Abstract excerpt
BACKGROUND: Histological transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) with anaplastic lymphoma kinase (ALK) positivity is extremely uncommon in ALK-positive NSCLC. To date, there have been limited reports regarding cases of SCLC transformation, and the optimal therapeutic strategies and prognosis for such patients remain unclear. This case is the first to describe the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.